CA1185183A - Castration chimique - Google Patents
Castration chimiqueInfo
- Publication number
- CA1185183A CA1185183A CA000413080A CA413080A CA1185183A CA 1185183 A CA1185183 A CA 1185183A CA 000413080 A CA000413080 A CA 000413080A CA 413080 A CA413080 A CA 413080A CA 1185183 A CA1185183 A CA 1185183A
- Authority
- CA
- Canada
- Prior art keywords
- composition
- chemical castration
- castration
- testes
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000126 substance Substances 0.000 title claims abstract description 15
- 238000012360 testing method Methods 0.000 claims abstract description 16
- 210000001550 testis Anatomy 0.000 claims abstract description 15
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims abstract description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 4
- 150000008064 anhydrides Chemical class 0.000 claims abstract description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 30
- 244000309464 bull Species 0.000 claims description 15
- 239000004310 lactic acid Substances 0.000 claims description 15
- 235000014655 lactic acid Nutrition 0.000 claims description 15
- 241000124008 Mammalia Species 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 3
- 150000002763 monocarboxylic acids Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 23
- 241001465754 Metazoa Species 0.000 abstract description 6
- 210000004392 genitalia Anatomy 0.000 abstract description 2
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 abstract description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000037396 body weight Effects 0.000 description 5
- 244000309466 calf Species 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 210000000918 epididymis Anatomy 0.000 description 3
- 201000010063 epididymitis Diseases 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Natural products OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Natural products OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000021595 spermatogenesis Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical compound C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010024870 Loss of libido Diseases 0.000 description 1
- 101100494762 Mus musculus Nedd9 gene Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000002570 interstitial cell Anatomy 0.000 description 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000002784 sclerotic effect Effects 0.000 description 1
- 210000002863 seminiferous tubule Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2963779A | 1979-04-13 | 1979-04-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1185183A true CA1185183A (fr) | 1985-04-09 |
Family
ID=21850077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000413080A Expired CA1185183A (fr) | 1979-04-13 | 1982-10-08 | Castration chimique |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS5933217A (fr) |
| AU (1) | AU556482B2 (fr) |
| CA (1) | CA1185183A (fr) |
| DE (1) | DE3229234C2 (fr) |
| FR (1) | FR2531858B1 (fr) |
| GB (1) | GB2126478B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101686692B (zh) * | 2007-04-18 | 2013-02-06 | 菲海姆技术公司 | 通过减少公猪的异味来改善肉质的方法 |
| KR101360830B1 (ko) * | 2013-11-21 | 2014-02-11 | (주)나비바이오텍 | 젖산을 함유한 동물의 난소 기능 불활 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1089361A (fr) * | 1976-01-23 | 1980-11-11 | Mostafa S. Fahim | Produit sterilisant injectable aux animaux males pour controler de facon selective la fonction des testicules |
| CA1189789A (fr) * | 1979-03-02 | 1985-07-02 | Gursaran P. Talwar | Procede de sterilisation des mammiferes |
-
1982
- 1982-08-05 DE DE19823229234 patent/DE3229234C2/de not_active Expired
- 1982-08-13 JP JP14159182A patent/JPS5933217A/ja active Pending
- 1982-08-19 FR FR8214338A patent/FR2531858B1/fr not_active Expired
- 1982-09-06 GB GB08225296A patent/GB2126478B/en not_active Expired
- 1982-09-06 AU AU88051/82A patent/AU556482B2/en not_active Ceased
- 1982-10-08 CA CA000413080A patent/CA1185183A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU556482B2 (en) | 1986-11-06 |
| AU8805182A (en) | 1984-03-15 |
| GB2126478A (en) | 1984-03-28 |
| JPS5933217A (ja) | 1984-02-23 |
| DE3229234C2 (de) | 1986-06-19 |
| FR2531858B1 (fr) | 1988-11-10 |
| FR2531858A1 (fr) | 1984-02-24 |
| GB2126478B (en) | 1986-06-18 |
| DE3229234A1 (de) | 1984-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Olson et al. | New developments in small animal population control | |
| US4520014A (en) | Treatment of diarrhoea | |
| CN110882215A (zh) | 安全广谱型聚维酮碘制剂及其制备方法与应用 | |
| CA1185183A (fr) | Castration chimique | |
| Kopcha et al. | Experimental uses of flunixin meglumine and phenylbutazone in food-producing animals | |
| Lawson et al. | The ERA strain of rabies vaccine | |
| Andriole | Water, acidosis, and experimental pyelonephritis | |
| US4339438A (en) | Injectable male animal sterilant for selectively controlling the function of testes | |
| US4156427A (en) | Injectable male animal sterilant for selectively controlling the function of testes | |
| Matschke | Microencapsulated diethylstilbestrol as an oral contraceptive in white-tailed deer | |
| Horta et al. | Possibility of reducing the luteolytic dose of cloprostenol in cyclic dairy cows | |
| Howey et al. | Evaluation of clinical and luteolytic effects of a novel prostaglandin analogue in normal and problem mares | |
| US4356189A (en) | Chemical castration | |
| Lubicz-Nawrocki et al. | The onset and duration of infertility in hamsters treated with α-chlorohydrin | |
| IE54150B1 (en) | Method of castration and contraception | |
| CA1189789A (fr) | Procede de sterilisation des mammiferes | |
| Yelich et al. | Synchronization response: Bos taurus vs. Bos indicus cattle | |
| EP0059057A1 (fr) | Traitement de la diarrhée | |
| US4191746A (en) | Sterilization process for mammals | |
| Botha | Berenil: efficacy against Babesia canis and comparison with phenamidine | |
| RU2062068C1 (ru) | Среда для разбавления и хранения спермы хряков | |
| RU2113847C1 (ru) | Способ лечения эндометритов у коров | |
| JPH06192102A (ja) | アルトレノゲストの新規な用途 | |
| RU2010573C1 (ru) | Способ лечения коров при задержании последа | |
| US3336190A (en) | Method of protecting the offspring of a herd of breeding swine from turbinate atrophy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEC | Expiry (correction) | ||
| MKEX | Expiry |